FDA inspection
Chamindra Laverty: FDA inspection ending Jan 14, 2026
FDA inspection 1298982 · Voluntary Action Indicated (VAI) · La Jolla, CA
Key facts
| Inspection ID | 1298982 |
|---|---|
| Firm | Chamindra Laverty |
| FEI number | 3042220198 |
| Address | Ucsd Altman Clinical And Translational Research Institute, 9452 Medical Center Dr |
| City | La Jolla |
| State | CA |
| ZIP | 92037 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jan 14, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data